Portfolio Company · Operating Co.

ClaritasRx

Healthcare Technology · Website

backed byQuesta Capital

CurrentHealthcare Technology

ClaritasRx

a portfolio company of

Questa Capital

Status on record: Current

PE Firm Index

Who owns ClaritasRx?

ClaritasRx is listed as a current portfolio company of Questa Capital on Questa Capital's own portfolio page.

From the company's website

Leading specialty pharmacy analytics for biopharma. Improve fill rates, medication adherence & patient outcomes with AI-driven market access insights.

Source: claritasrx.com, read November 2026

Company Snapshot

ClaritasRx is a Healthcare Technology company. Its owner on record, Questa Capital, is a firm. Questa Capital lists 22 companies in the index, 22 of them in Healthcare Technology.

SectorHealthcare Technology

Parent PE firmQuesta Capital

Ownership statusCurrent

WebsiteVisit ↗

About the owner

Questa Capital

Companies in the index: 22

Growth equity firm focused on healthcare services and technology.

Read the Questa Capital profile

Questions about ClaritasRx

Who owns ClaritasRx?

ClaritasRx is listed as a current portfolio company of Questa Capital on Questa Capital's own portfolio page.

What sector is ClaritasRx in?

ClaritasRx is in Healthcare Technology. Classified from the owner's portfolio label.

What else does Questa Capital own in Healthcare Technology?

Questa Capital lists 21 other Healthcare Technology companies in the index, including ACTO, Aerin Medical, Andros, Avive and Bicycle Health.

What is ClaritasRx's website?

ClaritasRx's website is https://www.claritasrx.com/.

Sources

Questa Capital
https://www.questacapital.com/portfolio

This profile is based on publicly available information and may be incomplete or outdated. PE Firm Index is not affiliated with ClaritasRx and does not provide investment advice.

Other portfolio companies of Questa Capital

6 of 21 shown

ACTO

Healthcare Technology

Aerin Medical

Medical Devices

Andros

Healthcare Technology

See the full Questa Capital portfolio.

Other Healthcare Technology companies held by Questa Capital

ACTO Aerin Medical Andros Avive

Bicycle Health Calyxo

Other Healthcare Technology portfolio companies

via Wavemaker 360 Health

3P Biopharmaceuticals

via Marlin Equity Partners

Browse PE-backed companies.

Is this your company?

Claiming is free and reviewed by hand. Correct facts and add your team.

Claim this profile Suggest a correction

Ownership

Parent PE firm

Questa Capital

Status: Current

Check this company's website

Check this company's website now

Free, in about two minutes: the verified issues a buyer or a customer's browser would meet. Runs on GTM Brain, by DevriX.

Observational measurements of this company's public website only. Not a rating of the company, its performance, its management, or its investment merit. Not investment advice. Request a correction or removal via Submit Update.

For PE-backed companies

DevriX

DevriX runs the websites, integrations and data that bring in revenue, as one accountable engineering and operations team, through acquisitions and exit.

Where DevriX helps

Value creation through the holdRevenue, data, web and AI run as one operating cadence, tied to EBITDA.Add-ons and carve-outsConsolidate or separate platforms and unify reporting after a deal.Exit readinessFind the technology and data issues a buyer's diligence would raise, before it does.

Send DevriX a short brief

A short form on devrix.com. No call to book.

Disclosure: PE Firm Index is maintained by Mario Peshev, who founded and runs DevriX. DevriX listing

Weekly PE M&A and market research, by email

The Growth Shuttle Insider is Mario Peshev's weekly newsletter for PE owners and operators. Each issue carries the week's private equity deals from this index, market data and research, and an essay from Mario.

Free. One email a week. Unsubscribe from any issue. Your address goes to beehiiv, the service that sends the Insider.

Research

The 2027 Digital Value Creation Baseline

1,407 PE-backed companies from 179 sponsors, measured from public sources in October 2026. 15% of service and product companies have the full path from search to CRM.

Read the research

Research by Growth Shuttle and DevriX.